Advertisement
Prostate cancer is the leading cause of cancer death in men in the U.S.,with more than 230,000 cases diagnosed annually.
LabCorp licensed the methylation technology from Veridex in 2007. Veridexlicensed this technology from OncoMethylome Sciences, S.A. (OMS).
Advertisement
About Veridex
Veridex, LLC, a Johnson & Johnson company, develops cancer diagnosticproducts that will enable earlier disease detection as well as more accuratestaging, monitoring and therapeutic selection. The company is initiallydeveloping two complementary product lines: CellSearch(TM) assays thatidentify, enumerate and characterize circulating tumor cells directly fromwhole blood; and GeneSearch(TM) assays that use molecular technology todiagnose, stage and more accurately characterize tumors. For additionalinformation, please visit www.veridex.com
SOURCE Veridex, LLC